Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation

Bone Marrow Transplant. 1999 Jul;24(2):219-21. doi: 10.1038/sj.bmt.1701870.

Abstract

This report describes a patient with acute-type adult T cell leukemia/lymphoma (ATLL) successfully treated by autologous CD34+ peripheral blood stem cell transplantation after fractionated total body irradiation and high-dose cytarabine and cyclophosphamide. A newly established inverse polymerase chain reaction method was used to demonstrate the disappearance of ATLL clonal cells. The patient achieved a sustained molecular remission after transplantation, but died from opportunistic infection 4 months after transplantation. Thus, autologous CD34+ peripheral blood stem cell transplantation is promising for this type of malignancy. However, a prudent clinical attitude toward immunological fragility after transplantation is needed for better outcome.

Publication types

  • Case Reports

MeSH terms

  • Antigens, CD34
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, T-Cell / genetics
  • Leukemia, T-Cell / pathology
  • Leukemia, T-Cell / therapy*
  • Middle Aged
  • Neoplastic Stem Cells
  • Polymerase Chain Reaction
  • Remission Induction
  • Transplantation, Autologous

Substances

  • Antigens, CD34